Leverage Health Solution, Cigna Ventures and Leaps by Bayer helped the skin condition treatment developer hike its total funding to approximately $67m.
Zerigo Health, a US-based developer of treatments for chronic skin conditions, has secured $43m in a series B round featuring corporates Bayer, Cigna and Leverage Health Solutions.
The round was led by healthcare venture capital fund 7wireVentures and included General Catalyst, Dragoneer, SV Health Investors, HIG Capital and Bluestem Capital.
Leverage Health Solutions invested directly while fellow health services provider Cigna did so through its Cigna Ventures unit and pharmaceutical and chemicals producer Bayer took part through subsidiary Leaps by…
